Home > Financial Ratios > SAKAR HEALTHCARE

SAKAR HEALTHCARE
EV/Core EBITDA

    Back to All Ratios
SAKAR HEALTHCARE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SAKAR HEALTHCARE
Please provide your vote to see the results

SAKAR HEALTHCARE Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 16.4810.8021.1713.2110.29

What is the latest EV/Core EBITDA ratio of SAKAR HEALTHCARE ?

The latest EV/Core EBITDA ratio of SAKAR HEALTHCARE is 16.48 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202616.48
Mar202510.80
Mar202421.17
Mar202313.21
Mar202210.29

How is EV/Core EBITDA of SAKAR HEALTHCARE Trending?

Years EV/Core EBITDA % Change
Mar2026 16.48
52.59
Mar2025 10.8
-48.98
Mar2024 21.17
60.26
Mar2023 13.21
28.38
Mar2022 10.29 -

Other Financial Ratios of SAKAR HEALTHCARE


Compare EV/Core EBITDA ratio of peers of SAKAR HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAKAR HEALTHCARE ₹2,155.2 Cr 5.2% -16.5% 153.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,204.0 Cr -0.1% -6.5% 3.8% Stock Analytics
DIVIS LABORATORIES ₹240,780.0 Cr -0.2% -5.5% 35.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,828.0 Cr 0.4% -8.2% 25.2% Stock Analytics
CIPLA ₹109,305.0 Cr 1.7% -2% -15.3% Stock Analytics
DR REDDYS LABORATORIES ₹108,759.0 Cr 4.9% 7.7% -2.5% Stock Analytics


SAKAR HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SAKAR HEALTHCARE

5.2%

-16.5%

153.1%

SENSEX

-1.5%

-1.2%

-11.8%


You may also like the below Video Courses